🇦🇪 Neuraceq in United Arab Emirates

Neuraceq (FLORBETABEN) regulatory status in United Arab Emirates.

Marketing authorisation

MOH

  • Marketing authorisation holder: LANTHEUS
  • Status: likely_approved

Neuraceq in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United Arab Emirates

Frequently asked questions

Is Neuraceq approved in United Arab Emirates?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Neuraceq in United Arab Emirates?

LANTHEUS holds the UAE marketing authorisation.